Nabriva Therapeutics Plc Shs N
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Nabriva Therapeutics Plc Shs N COM, CUSIP g63637113.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Nabriva Therapeutics Plc Shs N COM, CUSIP g63637113.